32 studies found for:    " September 24, 2008":" October 24, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Spatial Epidemiology of HIV Infection
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention:
2 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
3 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
4 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
5 Recruiting Analysis of HIV-1 Replication During Antiretroviral Therapy
Condition: HIV Infection
Intervention:
6 Completed
Has Results
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
Condition: HIV Infections
Intervention: Drug: Low dose Kaletra tablets
7 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
8 Completed Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
Conditions: Latent Tuberculosis;   HIV Infections
Intervention: Other: T-Spot.TB test
9 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
10 Completed Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada;   Drug: Atazanavir, Norvir and Truvada
11 Unknown  HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
Condition: HIV Infections
Intervention:
12 Terminated Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3-drug anti-HIV therapy;   Drug: Raltegravir
13 Terminated Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
14 Completed Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
15 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
16 Completed
Has Results
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)(COMPLETED)
Condition: Human Immunodeficiency Virus
Intervention: Drug: Comparator: raltegravir
17 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
18 Completed TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.
Condition: HIV
Intervention: Drug: Etravirine; Lopinavir; Ritonavir
19 Completed
Has Results
Relapse Prevention to Reduce HIV Among Women Prisoners
Conditions: Opioid Dependence;   HIV
Interventions: Drug: Placebo;   Drug: Buprenorphine
20 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years